Collaborative & Integrated Care at AAPP 2027 Annual Meeting

4 sessions on collaborative & integrated care · April 4–7, 2027, Louisville, KY. Compare collaborative & integrated care at other meetings →

Sunday, April 4

  • 12:15–13:15 · Lecture

    The Cycle of Chaos to Hope: Navigating Schizophrenia as a Mother and Caregiver

    Randye Kaye

    A keynote by a mother and advocate describing her family's experience with a son's schizophrenia, and how psychiatric pharmacists can partner with family caregivers to build trust, improve communication and support recovery.

    Schizophrenia & Psychosis · Serious Mental Illness

Monday, April 5

  • 08:00–09:00 · Lecture · Clinical Application Series

    Mental Health Care in Oncology: Highlighting a Lived Experience

    Kelly N. Gable

    A session drawing on a patient's lived experience and current evidence to examine anxiety, depression and distress in people with cancer. It covers barriers to integrated mental health care and the psychiatric pharmacist's role in supporting patients, including menopause related to cancer treatment.

    Anxiety Disorders · Depression · Medical Comorbidity & C-L Psychiatry

  • 12:20–13:20 · Lecture · Clinical Application Series

    Improving Psychotropic Prescribing in Foster Care: The Essential Role of the BCPP

    Danielle L. Stutzman

    Looks at why youth in foster care often receive complex psychotropic regimens and how board-certified psychiatric pharmacists can support safer prescribing. Covers stewardship approaches, barriers to including pharmacists on foster care teams, and state advocacy efforts.

    Child & Adolescent · Deprescribing & Polypharmacy · Practice, Policy & Workforce

Wednesday, April 7

  • 07:00–08:00 · Lecture · Clinical Application Series

    Psychotropic Stewardship from Startup to Sustainability

    April Fulbright

    Offers a practical, stepwise roadmap for building, launching and expanding a psychotropic stewardship program in different practice settings. Covers core program elements and strategies for growth based on resources, staffing and organizational priorities.

    Deprescribing & Polypharmacy · Practice, Policy & Workforce

Other topics at this meeting

Drug Interactions & Safety 5Practice, Policy & Workforce 5Medical Comorbidity & C-L Psychiatry 5Antipsychotic Prescribing 4Anxiety Disorders 4Education & Training 4Schizophrenia & Psychosis 4Deprescribing & Polypharmacy 3Depression 3Measurement-Based Care & Diagnosis 3Pharmacogenomics & Precision Psychiatry 3Child & Adolescent 2

Full program overview →